These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1531815)

  • 21. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants and the peripheral nervous system.
    Husstedt IW; Kuhs H; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():147-8. PubMed ID: 2530774
    [No Abstract]   [Full Text] [Related]  

  • 24. [The group of selective antidepressants, serotonin reuptake inhibitors].
    Rigal J
    Ann Med Psychol (Paris); 1986 Apr; 144(4):422-9. PubMed ID: 3813335
    [No Abstract]   [Full Text] [Related]  

  • 25. New antidepressants and 5-HT uptake inhibitors.
    Montgomery SA
    Acta Psychiatr Scand Suppl; 1989; 350():107-16. PubMed ID: 2530760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adverse effects: priapism caused by paroxetine].
    Bertholon F; Krajewski Y; el Allali A
    Ann Med Psychol (Paris); 1996 May; 154(2):145-6; discussion 146-7. PubMed ID: 8694403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL; Cohn JB; Walshe T; Cohn CK; Feighner JP; Fieve RR; Halikas JP; Hartford JT; Hearst ED; Settle EC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal dose regimen for paroxetine.
    Dunner DL; Dunbar GC
    J Clin Psychiatry; 1992 Feb; 53 Suppl():21-6. PubMed ID: 1531817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
    Drug Ther Bull; 1991 Jun; 29(12):46-7. PubMed ID: 1834449
    [No Abstract]   [Full Text] [Related]  

  • 32. New drug development for post-traumatic stress disorder.
    Berlant J
    Curr Opin Investig Drugs; 2003 Jan; 4(1):37-41. PubMed ID: 12625026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panic disorder: the potential role of serotonin reuptake inhibitors.
    Sheehan DV; Zak JP; Miller JA; Fanous BS
    J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms.
    Sindrup SH; Gram LF; Brøsen K; Eshøj O; Mogensen EF
    Pain; 1990 Aug; 42(2):135-144. PubMed ID: 2147235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of selective serotonin reuptake inhibitors.
    Bech P
    Psychopharmacol Ser; 1989; 7():81-93. PubMed ID: 2687870
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors.
    Edwards JG
    BMJ; 1992 Jun; 304(6843):1644-6. PubMed ID: 1633513
    [No Abstract]   [Full Text] [Related]  

  • 39. Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation study.
    Sindrup SH; Grodum E; Gram LF; Beck-Nielsen H
    Ther Drug Monit; 1991 Sep; 13(5):408-14. PubMed ID: 1835549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical pharmacology of paroxetine in healthy subjects.
    Raptopoulos P; McClelland GR; Jackson D
    Acta Psychiatr Scand Suppl; 1989; 350():46-8. PubMed ID: 2530788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.